![Edward Dulac](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward Dulac
Director of Finance/CFO at
INTELLIA THERAPEUTICS, INC.
Net worth: 2 M $ as of 30/05/2026
Profile
Currently, Edward J. Dulac occupies the position of Chief Financial Officer & Accounting Officer at Fate Therapeutics, Inc. In the past he was Principal at CVS, Inc. (Maryland), Vice President-Business Development & Strategy at Celgene Corp., Principal at Pfizer (St. Louis), Principal at Brooks Eckerd Pharmacy, Research Analyst at Barclays Capital, Inc. and Research Analyst at Barclays Capital Securities Ltd. He received an undergraduate degree from the University of Pittsburgh and an MBA from Kelley School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2026 | 115,416 ( 0.08% ) | 2 M $ | 30/05/2026 |
Edward Dulac active positions
| Companies | Position | Start |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Director of Finance/CFO | 21/07/2024 |
Former positions of Edward Dulac
| Companies | Position | End |
|---|---|---|
| FATE THERAPEUTICS, INC. | Director of Finance/CFO | 13/06/2024 |
| CELGENE | Corporate Officer/Principal | 31/01/2020 |
Barclays Capital Securities Ltd.
 Barclays Capital Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 24/07/2011 |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Corporate Officer/Principal | 29/11/2007 |
Brooks Eckerd Pharmacy | Corporate Officer/Principal | 29/06/2001 |
Training of Edward Dulac
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
84
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Barclays Capital Securities Ltd.
Barclays Capital Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Brooks Eckerd Pharmacy | |
CVS, Inc. (Maryland)
 CVS, Inc. (Maryland) Other Consumer ServicesConsumer Services Provides engineering, maintenance, and control programming services for video, audio, and control system | Consumer Services |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
- Stock Market
- Insiders
- Edward Dulac
